|
|
||||||||
Eur J Cardiothorac Surg 2004;25:971-977
© 2004 Elsevier Science NL
a Department of Cardiovascular Surgery, Albert-Ludwigs-University Medical Center, Hugstetter Str. 55, D-79106 Freiburg, Germany
b Department of Cardiology, Albert-Ludwigs-University Medical Center, Freiburg, Germany
Received 21 October 2003; received in revised form 26 January 2004; accepted 28 January 2004.
* Corresponding author. Tel.: +49-761-270-2818; fax: +49-761-270-2550
e-mail: martin{at}ch11.ukl.uni-freiburg.de
Objectives: Elevated pulmonary vascular resistance (PVR) unresponsive to pharmacological intervention is a major limitation in heart transplantation (HTX). The post-operative course of these patients is associated with an increased risk of life-threatening right heart failure. We evaluated the efficiency of an implantable left ventricular assist device (LVAD) to decrease PVR by unloading the left ventricle and to lower the risk of later orthotopic HTX. Methods: Six patients with end-stage heart failure (NYHA class IV) and fixed pulmonary hypertension (PVR 5.7±0.7, range 4.46.5 Wood units) were analyzed. Despite maximal pharmacological intervention at initial evaluation (oxygen inhalation, nitrates, alprostadil infusion) PVR could not be reduced to under 2.5 Wood units. Four patients received a TCI Heartmate, one patient a Novacor, and one patient a Jarvik 2000. Results: All patients survived the LVAD implantation, four patients could be discharged from hospital. Cardiac index and pulmonary artery pressure values returned to normal during the early post-operative phase. After a mean support time of 191±86 days PVR had fallen to 2.0±1.2 (range 0.83.6) Wood units. All patients could be bridged to transplantation, one patient died 3 months after transplant, five patients are still alive after a mean follow-up of 16.2±10.5 months. Conclusions: Mechanical support using an implantable LVAD is a very efficient approach with an acceptable risk to treat severe pulmonary hypertension in end-stage heart failure patients before HTX. Adequate reduction of PVR can be expected within 36 months. Subsequent HTX is associated with a good outcome.
Key Words: Heart failure Pulmonary hypertension Transplantation Ventricular assist device
This article has been cited by other articles:
![]() |
H. Liden, A. Haraldsson, S.-E. Ricksten, U. Kjellman, and L. Wiklund Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Cardarelli, M. Salim, J. Love, S. Simone, J. Tumulty, D. Conway, and B. Griffith Berlin heart as a bridge to recovery for a failing fontan. Ann. Thorac. Surg., March 1, 2009; 87(3): 943 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Succi, L. F. P. Moreira, A. A. Leirner, R. S. Silva, and N. A.G. Stolf Cavopulmonary anastomosis improves left ventricular assist device support in acute biventricular failure Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 528 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Tedford, A. R. Hemnes, S. D. Russell, I. S. Wittstein, M. Mahmud, A. L. Zaiman, S. C. Mathai, D. R. Thiemann, P. M. Hassoun, R. E. Girgis, et al. PDE5A Inhibitor Treatment of Persistent Pulmonary Hypertension After Mechanical Circulatory Support Circ Heart Fail, November 1, 2008; 1(4): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ann. Thorac. Surg., October 1, 2008; 86(4): 1227 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Geisen, C. Heilmann, F. Beyersdorf, C. Benk, M. Berchtold-Herz, C. Schlensak, U. Budde, and B. Zieger Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 679 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Viklicky, I. Netuka, M. Urbanova, M. Adamec, J. Maly, L. Voska, and E. Pokorna Kidney transplantation from a brain-dead heart transplant candidate treated with biventricular assist device: 12-month follow-up NDT Plus, February 1, 2008; 1(1): 34 - 35. [Full Text] [PDF] |
||||
![]() |
M. Markl, C. Benk, D. Klausmann, A. F. Stalder, A. Frydrychowicz, J. Hennig, and F. Beyersdorf Three-dimensional magnetic resonance flow analysis in a ventricular assist device. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1471 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Esmore, P. Spratt, R. Larbalestier, S. Tsui, A. Fiane, P. Ruygrok, D. Meyers, and J. Woodard VentrAssistTM left ventricular assist device: clinical trial results and Clinical Development Plan update Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 735 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Etz, H. A. Welp, T. D.T. Tjan, A. Hoffmeier, E. Weigang, H. H. Scheld, and C. Schmid Medically Refractory Pulmonary Hypertension: Treatment With Nonpulsatile Left Ventricular Assist Devices Ann. Thorac. Surg., May 1, 2007; 83(5): 1697 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hendry Invited commentary Ann. Thorac. Surg., May 1, 2007; 83(5): 1705 - 1706. [Full Text] [PDF] |
||||
![]() |
D. Zimpfer, P. Zrunek, S. Sandner, H. Schima, M. Grimm, A. Zuckermann, E. Wolner, and G. Wieselthaler Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 698 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zimpfer, P. Zrunek, W. Roethy, M. Czerny, H. Schima, L. Huber, M. Grimm, A. Rajek, E. Wolner, and G. Wieselthaler Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klotz, J. Stypmann, H. Welp, C. Schmid, G. Drees, A. Rukosujew, and H. H. Scheld Does Continuous Flow Left Ventricular Assist Device Technology Have a Positive Impact on Outcome Pretransplant and Posttransplant? Ann. Thorac. Surg., November 1, 2006; 82(5): 1774 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.V. Potapov, Y. Weng, M. Jurmann, H. Lehmkuhl, and R. Hetzer Bridging to transplantability with a ventricular assist device J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 930 - 930. [Full Text] [PDF] |
||||
![]() |
S. P. Salzberg, M. L. Lachat, K. von Harbou, G. Zund, and M. I. Turina Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 222 - 225. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |